March 3, 2022

Negative news for Coca Cola, Melrose and PageGroup. 3rd March 22

COCA COLA HBC (LON:CCH); Stopped production Kyiv plant on 24/02. Generate 20% of volumes from Russia and Ukraine. No longer prudent to give guidance. Coca Cola HBC AG is a..

Poolbeg Pharma reports a period of great progress

Following on from Poolbeg Pharma plc (LON:POLB) audited results for the period ended 31 December 2021, DirectorsTalk Interviews caught up with Chairman Cathal Friel for his thoughts on the update...

Serinus Energy ‘offers healthy earnings progression’ says Shore Capital analyst

Serinus Energy plc (LON:SENX) is the topic of conversation when Shore Capital’s Analyst Craig Howie caught up with DirectorsTalk for an exclusive interview. Q1: You recently took part in a..

Northbridge Industrial Services begin share buyback programme

Northbridge Industrial Services Plc (LON:NBI), the industrial services and rental company, has announcesd that it has entered into irrevocable, non-discretionary arrangements with Shore Capital Stockbrokers Limited to repurchase ordinary shares..

KEFI Gold and Copper development activities recommence at Tulu Kapi

KEFI Gold and Copper PLC (LON:KEFI), the gold and copper exploration and development company with projects in the Federal Democratic Republic of Ethiopia and the Kingdom of Saudi Arabia, has..

Morses Club report strong trading during the period

Morses Club PLC (LON:MCL), an established provider of non-standard financial services, has provided the following trading update for the 52-week period to 26th February 2022 (“FY22”). Trading The Group traded..

Poolbeg Pharma makes excellent progress post IPO and momentum building

Poolbeg Pharma plc (LON:POLB) has announced its audited results for the period ended 31 December 2021. These results follow the Company’s spin-out from Open Orphan plc and the subsequent listing..

Boku Inc notice of results, analyst briefing and investor presentation

Boku Inc (LON:BOKU), a leading provider of mobile payment solutions, has said that it will announce its results for the year ended 31 December 2021 on Tuesday 29 March 2022...

Allergy Therapeutics results and US readiness plan underway including two pivotal trials

Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced its unaudited interim results for the six months ended 31 December 2021. ·      Portfolio focused..

Search

Funds

March 3, 2022

Search

Funds

March 3, 2022

FTSE 100

Funds